1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Radiotheranostics Market- Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Radiotheranostics Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Radiotheranostics Market- Breakup by Radioisotope
6.1 Iodine-131
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Iodine-123
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Gallium-68
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2024-2032)
6.4 Lutetium-177
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2024-2032)
6.5 18F with Y-90
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2018-2023)
6.5.3 Market Segmentation
6.5.4 Market Forecast (2024-2032)
6.6 Others
6.6.1 Historical and Current Market Trends (2018-2023)
6.6.2 Market Forecast (2024-2032)
6.7 Attractive Investment Proposition by Radioisotope
7 Global Radiotheranostics Market - Breakup by Approach
7.1 Targeted Therapeutic
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Targeted Diagnostic
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Attractive Investment Proposition by Approach
8 Global Radiotheranostics Market- Breakup by Application
8.1 Oncology
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.3.1 Thyroid Cancer
8.1.3.2 Neuroendocrine Tumor
8.1.3.3 Hepatocellular Carcinoma
8.1.3.4 Prostate Cancer
8.1.3.5 Others
8.1.4 Market Forecast (2024-2032)
8.2 Non-oncology
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.3.1 Neurological Disorders
8.2.3.2 Arthritis
8.2.3.3 Others
8.2.4 Market Forecast (2024-2032)
8.3 Attractive Investment Proposition by Application
9 Global Radiotheranostics Market– Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2018-2023)
9.1.1.3 Market Breakup by Radioisotope
9.1.1.4 Market Breakup by Approach
9.1.1.5 Market Breakup by Application
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2024-2032)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2018-2023)
9.1.2.3 Market Breakup by Radioisotope
9.1.2.4 Market Breakup by Approach
9.1.2.5 Market Breakup by Application
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2024-2032)
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2018-2023)
9.2.1.3 Market Breakup by Radioisotope
9.2.1.4 Market Breakup by Approach
9.2.1.5 Market Breakup by Application
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2024-2032)
9.2.2 France
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2018-2023)
9.2.2.3 Market Breakup by Radioisotope
9.2.2.4 Market Breakup by Approach
9.2.2.5 Market Breakup by Application
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2024-2032)
9.2.3 United Kingdom
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2018-2023)
9.2.3.3 Market Breakup by Radioisotope
9.2.3.4 Market Breakup by Approach
9.2.3.5 Market Breakup by Application
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2024-2032)
9.2.4 Italy
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2018-2023)
9.2.4.3 Market Breakup by Radioisotope
9.2.4.4 Market Breakup by Approach
9.2.4.5 Market Breakup by Application
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2024-2032)
9.2.5 Spain
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2018-2023)
9.2.5.3 Market Breakup by Radioisotope
9.2.5.4 Market Breakup by Approach
9.2.5.5 Market Breakup by Application
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2024-2032)
9.2.6 Others
9.2.6.1 Historical and Current Market Trends (2018-2023)
9.2.6.2 Market Forecast (2024-2032)
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2018-2023)
9.3.1.3 Market Breakup by Radioisotope
9.3.1.4 Market Breakup by Approach
9.3.1.5 Market Breakup by Application
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2024-2032)
9.3.2 Japan
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2018-2023)
9.3.2.3 Market Breakup by Radioisotope
9.3.2.4 Market Breakup by Approach
9.3.2.5 Market Breakup by Application
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2024-2032)
9.3.3 India
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2018-2023)
9.3.3.3 Market Breakup by Radioisotope
9.3.3.4 Market Breakup by Approach
9.3.3.5 Market Breakup by Application
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2024-2032)
9.3.4 South Korea
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2018-2023)
9.3.4.3 Market Breakup by Radioisotope
9.3.4.4 Market Breakup by Approach
9.3.4.5 Market Breakup by Application
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2024-2032)
9.3.5 Australia
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2018-2023)
9.3.5.3 Market Breakup by Radioisotope
9.3.5.4 Market Breakup by Approach
9.3.5.5 Market Breakup by Application
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2024-2032)
9.3.6 Indonesia
9.3.6.1 Market Drivers
9.3.6.2 Historical and Current Market Trends (2018-2023)
9.3.6.3 Market Breakup by Radioisotope
9.3.6.4 Market Breakup by Approach
9.3.6.5 Market Breakup by Application
9.3.6.6 Key Players
9.3.6.7 Market Forecast (2024-2032)
9.3.7 Others
9.3.7.1 Historical and Current Market Trends (2018-2023)
9.3.7.2 Market Forecast (2024-2032)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2018-2023)
9.4.1.3 Market Breakup by Radioisotope
9.4.1.4 Market Breakup by Approach
9.4.1.5 Market Breakup by Application
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2024-2032)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2018-2023)
9.4.2.3 Market Breakup by Radioisotope
9.4.2.4 Market Breakup by Approach
9.4.2.5 Market Breakup by Application
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2024-2032)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2018-2023)
9.4.3.2 Market Forecast (2024-2032)
9.5 Middle East and Africa
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Radioisotope
9.5.4 Market Breakup by Approach
9.5.5 Market Breakup by Application
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2024-2032)
9.6 Attractive Investment Proposition by Region
10 Global Radiotheranostics Market– Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Share by Key Players
10.4 Market Player Positioning
10.5 Top Winning Strategies
10.6 Competitive Dashboard
10.7 Company Evaluation Quadrant
11 Profiles of Key Players
11.1 Actinium Pharmaceuticals, Inc.
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 SWOT Analysis
11.1.5 Major News and Events
11.2 IsoTherapeutics Group, LLC
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 SWOT Analysis
11.2.5 Major News and Events
11.3 ITM Isotope Technologies Munich SE
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Lantheus Holdings, Inc.
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 SWOT Analysis
11.4.5 Major News and Events
11.5 Life Molecular Imaging GmbH
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 SWOT Analysis
11.5.5 Major News and Events
11.6 Novartis AG
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Business Strategies
11.6.4 SWOT Analysis
11.6.5 Major News and Events
11.7 Radiomedix, Inc.
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Business Strategies
11.7.4 SWOT Analysis
11.7.5 Major News and Events
11.8 Telix Pharmaceuticals Limited
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Business Strategies
11.8.4 SWOT Analysis
11.8.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
12 Global Radiotheranostics Market- Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.1.5 Impact Analysis
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 Strategic Recommendations
14 Appendix